Loading
Insider filings for Vascular Solutions Inc are scarce in the SEC (Form 4) feed, the latest one published on 22 February 2017. This page will fill in as new trades are disclosed. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
FY ended December 2015 · cache
25 of 64 declarations
Vascular Solutions Inc is a company focused on developing medical devices for the treatment of vascular diseases. It is listed on NASDAQ under the ticker VASC.
| Fiscal year end | Revenue | Net income | Diluted EPS | Filing |
|---|---|---|---|---|
| Dec 2015 | 147.2 m USD | 10.5 m USD | 0.58 USD | 10-K |
| Dec 2014 | 126.1 m USD | 12.7 m USD | 0.72 USD | 10-K |
| Dec 2013 | 110.5 m USD | 11.1 m USD | 0.65 USD | 10-K |
| Dec 2012 | 98.4 m USD | 9.9 m USD | 0.60 USD | 10-K |
| Dec 2011 | 90.0 m USD | 9.7 m USD | 0.57 USD | 10-K |
Amounts in USD, as filed (forms 10-K, 20-F or 40-F). Source: SEC EDGAR.